Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Co-Diagnostics (CODX) Tops Q2 EPS by 43c
August 14, 2025 4:02 PM EDTCo-Diagnostics (NASDAQ: CODX) reported Q2 EPS of ($0.23), $0.43 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $200 thousand.
For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.
... More